| Stage | DDS | % of rev | PSN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.5B | 100.00% | $1.7B | 100.00% | PSN ×1.08 |
| Gross profit | $617M | 40.33% | $382M | 23.15% | DDS +17.2pp |
| Operating income | $129M | 8.45% | $104M | 6.29% | DDS +2.2pp |
| Pre-tax income | $127M | 8.31% | $88M | 5.32% | DDS +3.0pp |
| Net income | $98M | 6.38% | $67M | 4.08% | DDS +2.3pp |
| Stage | DDS | PSN | Gap · A − B |
|---|---|---|---|
| Revenue | $1.5B100.00% | $1.7B100.00% | PSN ×1.08 |
| Gross profit | 40.33%$617M | 23.15%$382M | DDS +17.2pp |
| Operating income | 8.45%$129M | 6.29%$104M | DDS +2.2pp |
| Pre-tax income | 8.31%$127M | 5.32%$88M | DDS +3.0pp |
| Net income |
| 6.38%$98M |
| 4.08%$67M |
| DDS +2.3pp |
No shared counterparties.